4-methyl-5-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,3-thiazol-2-amine
- $252 - $502.08
- Product name: 4-methyl-5-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,3-thiazol-2-amine
- CAS: 937681-59-9
- MF: C13H12N4OS
- MW: 272.33
- EINECS:
- MDL Number:MFCD09037091
- Synonyms:4-methyl-5-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,3-thiazol-2-amine;2-Thiazolamine, 4-methyl-5-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-
3 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 5MG
- 500mg
- ManufacturerAK Scientific
- Product number3729AF
- Product description4-Methyl-5-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,3-thiazol-2-amine
- Packaging500mg
- Price$390
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0372875
- Product description4-METHYL-5-[3-(4-METHYLPHENYL)-1,2,4-OXADIAZOL-5-YL]-1,3-THIAZOL-2-AMINE 95.00%
- Packaging5MG
- Price$502.08
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number038722
- Product description4-Methyl-5-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,3-thiazol-2-amine
- Packaging500mg
- Price$252
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 3729AF | 4-Methyl-5-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,3-thiazol-2-amine | 500mg | $390 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0372875 | 4-METHYL-5-[3-(4-METHYLPHENYL)-1,2,4-OXADIAZOL-5-YL]-1,3-THIAZOL-2-AMINE 95.00% | 5MG | $502.08 | 2021-12-16 | Buy |
Matrix Scientific | 038722 | 4-Methyl-5-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1,3-thiazol-2-amine | 500mg | $252 | 2021-12-16 | Buy |
Properties
Boiling point :493.3±55.0 °C(Predicted)
Density :1.317±0.06 g/cm3(Predicted)
pka :2.71±0.10(Predicted)
Density :1.317±0.06 g/cm3(Predicted)
pka :2.71±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|